Ardelyx (ARDX) Research & Development (2013 - 2026)
Ardelyx (ARDX) reported Research & Development of $20.2 million for Q1 2026, up 35.15% on a YoY basis from $14.9 million in Q1 2025, and down 11.67% quarter-over-quarter from $22.9 million in Q4 2025.
Ardelyx (ARDX) Research & Development (2013 - 2026) Analysis & Trends
Ardelyx has reported Research & Development for 14 years, with the latest figure at $20.2 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development rose 35.15% year-over-year to $20.2 million; the trailing twelve-month figure through Mar 2026 stood at $76.8 million (up 35.47% YoY), and the FY2025 full-year result was $71.5 million, up 36.72% from the prior year.
- Research & Development for Q1 2026 stood at $20.2 million, down from $22.9 million in the prior quarter.
- The five-year high for Research & Development was $22.9 million in Q4 2025, with the low at $7.5 million in Q3 2022.
- Historically, Research & Development has averaged $12.6 million across 5 years, with a median of $10.6 million in 2024.
- Annual changes were most pronounced in 2022 — Research & Development plunged 68.49% — and 2024, when it surged 77.26%.
- Ardelyx's Research & Development stood at $9.1 million in 2022, then rose by 4.18% to $9.5 million in 2023, then soared by 43.49% to $13.7 million in 2024, then jumped by 67.25% to $22.9 million in 2025, then declined by 11.67% to $20.2 million in 2026.
- The last three Research & Development figures came in at $20.2 million (Q1 2026), $22.9 million (Q4 2025), and $18.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | 20.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.19 Mn |
| Dec 31, 2025 | 22.86 Mn |
| Sep 30, 2025 | 18.07 Mn |
| Jun 30, 2025 | 15.67 Mn |
| Mar 31, 2025 | 14.94 Mn |
| Dec 31, 2024 | 13.67 Mn |
| Sep 30, 2024 | 15.31 Mn |
| Jun 30, 2024 | 12.76 Mn |
| Mar 31, 2024 | 10.58 Mn |
| Dec 31, 2023 | 9.52 Mn |
| Sep 30, 2023 | 8.64 Mn |
| Jun 30, 2023 | 8.28 Mn |
| Mar 31, 2023 | 9.09 Mn |
| Dec 31, 2022 | 9.14 Mn |
| Sep 30, 2022 | 7.47 Mn |
| Jun 30, 2022 | 9.74 Mn |
| Mar 31, 2022 | 8.85 Mn |
| Dec 31, 2021 | 20.97 Mn |
| Sep 30, 2021 | 23.70 Mn |
| Jun 30, 2021 | 26.02 Mn |